Important Disclosure

By accessing and using the website the reader agrees to be bound legally by the ‘Terms & Conditions’ for accessing and use of the information presented. These can be found under “Links” at the top of the page.

Arculus Funds Management Pty Ltd (ABN 74 661 739 340) is an Authorised Representative (No. 1298896) and wholly owned subsidiary of GCI Australia Pty Ltd (ABN 68 140 364 576; AFSL No. 346034).

Important: This document has been prepared and issued by Arculus Funds Management. We are authorised by GCI Australia to provide particular financial services to those who qualify as a ‘Wholesale Client’ in accordance with the Corporations Act. This document has been prepared for, and to be dispatched to, our Wholesale Client(s), and is provided on the basis that it is not to be forwarded to any other person or audience which includes or may include a ‘Retail Client(s)’.

Information & Advice: The information presented in this email and any attachments may include opinion, product-rating (from a third-party research provider) or recommendation about a financial product(s). If so, it is ‘General Advice’, based on the investment merits of the product(s) alone. It is not ‘Personal Advice’ because it takes no account of the suitability or appropriateness of the product(s) concerned for your or anyone else’s investment objectives, financial situation or needs. Before deciding to buy, continue to hold or sell a product based on the information presented here, consider carefully the appropriateness of doing so, given your circumstances. If you are considering acquiring a product mentioned here, which is the subject of a current Product Disclosure Statement (PDS), you should read it before making a decision. Applications can only be made using the form in the PDS.

Warning: Past performance is not a reliable indicator of future performance. Derivatives are leveraged products, which means gains and losses are magnified, and you may lose substantially more than your initial investment. Opinions, ratings and recommendations may change without notice. We do not endorse any information from third-party research providers that we provide to you unless we say so specifically.

Protect confidentiality: The information contained in or attaching to this email is intended only for the named addressee and may contain privileged and confidential information. If you are not the named addressee, any dissemination distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the message and deleting it from your computer.

Taylor Rule Sensitivity Analysis – July 2026

Reports / News

Want to know more?

Useful links